CA2278153A1 - Proteines secretees et polynucleotides codant ces proteines - Google Patents

Proteines secretees et polynucleotides codant ces proteines Download PDF

Info

Publication number
CA2278153A1
CA2278153A1 CA002278153A CA2278153A CA2278153A1 CA 2278153 A1 CA2278153 A1 CA 2278153A1 CA 002278153 A CA002278153 A CA 002278153A CA 2278153 A CA2278153 A CA 2278153A CA 2278153 A1 CA2278153 A1 CA 2278153A1
Authority
CA
Canada
Prior art keywords
polynucleotide
seq
protein
amino acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002278153A
Other languages
English (en)
Inventor
Kenneth Jacobs
John M. Mccoy
Edward R. Lavallie
Lisa A. Racie
David Merberg
Maurice Treacy
Vikki Spaulding
Michael J. Agostino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2278153A1 publication Critical patent/CA2278153A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Transplantation (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention concerne de nouveaux polynucléotides et les protéines codées par ces polynucléotides.
CA002278153A 1997-01-21 1998-01-21 Proteines secretees et polynucleotides codant ces proteines Abandoned CA2278153A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US7210397P 1997-01-21 1997-01-21
US87703597A 1997-06-16 1997-06-16
US1004798A 1998-01-20 1998-01-20
US08/877,035 1998-01-20
US09/010,047 1998-01-20
US60/072,103 1998-01-20
PCT/US1998/001007 WO1998031802A2 (fr) 1997-01-21 1998-01-21 Proteines secretees et polynucleotides codant ces proteines

Publications (1)

Publication Number Publication Date
CA2278153A1 true CA2278153A1 (fr) 1998-07-23

Family

ID=27359139

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002278153A Abandoned CA2278153A1 (fr) 1997-01-21 1998-01-21 Proteines secretees et polynucleotides codant ces proteines

Country Status (5)

Country Link
EP (1) EP0972026A2 (fr)
JP (1) JP2002512507A (fr)
AU (1) AU6031398A (fr)
CA (1) CA2278153A1 (fr)
WO (1) WO1998031802A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0949332A3 (fr) * 1998-04-01 2001-03-28 Smithkline Beecham Plc Polypeptides HSSCRG1
EP1180151A2 (fr) * 1999-05-28 2002-02-20 Sugen, Inc. Proteines kinases
JP2001103974A (ja) * 1999-10-08 2001-04-17 Susumu Kiyono タンパク質Ｒｉｍ２

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68928137T2 (de) * 1988-11-18 1998-02-19 Oregon State Dopamin-rezeptoren und gene
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
EP0510691B1 (fr) * 1991-04-26 2004-11-03 Osaka Bioscience Institute ADN codant un antigène de surface cellulaire humaine
WO1994007916A1 (fr) * 1992-10-07 1994-04-14 Merck & Co., Inc. Recepteur d'hormone steroide humain neri
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
ES2240981T3 (es) * 1994-12-06 2005-10-16 Immunex Corporation Citocina denominada lerk-7.
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
AU1532697A (en) * 1996-01-12 1997-08-01 Genetics Institute Inc. Beta-chemokine, h1305 (mcp-2)

Also Published As

Publication number Publication date
EP0972026A2 (fr) 2000-01-19
WO1998031802A2 (fr) 1998-07-23
AU6031398A (en) 1998-08-07
WO1998031802A3 (fr) 1998-11-19
JP2002512507A (ja) 2002-04-23

Similar Documents

Publication Publication Date Title
CA2269755A1 (fr) Proteines secretees et polynucleotides codant ces proteines
CA2278595A1 (fr) Proteines secretees et polynucleotides codant celles-ci
CA2285554A1 (fr) Proteines secretees et polynucleotides les codant
CA2288343A1 (fr) Proteines secretees et polynucleotides les codant
CA2283195A1 (fr) Proteines secretees et polynucleotides les codant
CA2274732A1 (fr) Proteines secretees et polynucleotides codant pour lesdites proteines
CA2306457A1 (fr) Proteines secretees et polynucleotides les codant
CA2278770A1 (fr) Proteines secretees et polynucleotides les codant
CA2281059A1 (fr) Proteines secretees et polynucleotides les codant
WO1997046682A2 (fr) Polynucleotides issus des proteines secretees par l'adultes humains et codant pour les pbmc
CA2283193A1 (fr) Proteines secretees et polynucleotides codant ces dernieres
CA2276088A1 (fr) Proteines secretees et polynucleotides les codant
AU758823B2 (en) Secreted proteins
CA2284109A1 (fr) Proteines secretees et polynucleotides les codant
CA2278153A1 (fr) Proteines secretees et polynucleotides codant ces proteines
CA2273845A1 (fr) Proteines secretees et polynucleotides les codant
CA2281015A1 (fr) Proteines secretees et polynucleotides codant pour celles-ci
CA2276085A1 (fr) Proteines secretees et polynucleotides les codant
WO1998020130A2 (fr) Proteines secretees et polynucleotides les codant
WO1998001553A2 (fr) Proteines secretees et polynucleotides codant lesdites proteines
EP1007660A2 (fr) Proteines secretees et polynucleotides les codant
CA2272050A1 (fr) Proteines secretes et polynucleotides qui les codent
CA2280968A1 (fr) Proteines secretees et polynucleotides les codant
CA2291477A1 (fr) Semaphorine e d'origine humaine et polynucleotides codant cette semaphorine e
CA2295212A1 (fr) Proteines secretees et polynucleotides codant ces proteines

Legal Events

Date Code Title Description
FZDE Dead